depression semaglutide People with pre-existing or anxiety were less likely to have mental health worsening while taking a GLP-1 medication, observational Swedish data suggested. https://www.medpagetoday.com/psychiatry/generalpsychiatry/120515 New Data Show Semaglutide's Effects

Is it time for a new algorithm for the pharmacotherapy of steroid-induced diabetes

Comprehensive blood work is essential before treatment begins

Diabetes Obes Metab 2020;22:631-9

Retatrutide could trigger: price adjustments for existing GLP-1 drugs innovation of new multi-agonist peptides expansion of obesity-drug insurance coverage more investment into metabolic-disease research Impact on UK Healthcare If retatrutide delivers the same results in real-world use as in trials, the UK could see: reduced long-term obesity rates fewer diabetes complications lower cardiovascular risk reduced NHS burden over decades The UK typically moves more slowly than the U.S

Promising results have been achieved in their implementation in non-alcoholic fatty liver disease and neurodegenerative disorders, as well as in alcohol dependency therapy (31, 32)

The medication takes 4 to 5 weeks to reach steady-state blood levels, which is why the dose titration schedule starts low and increases gradually